Skip to main content
. 2020 Jan 3;51:102547. doi: 10.1016/j.ebiom.2019.11.008

Table 2.

Demographic, biochemical and clinical parameters of the patients with highly aggressive PCa (Cohort 2). PSA: Prostate specific antigen; SigPCa: Significant PCa defined as Gleason score ≥ 7.

Parameter
Patients [n] 42
Age, years [median (IQR)] 75 (69–81)
PSA levels, ng/mL [median (IQR)] 62.0 (36.2–254.5)
SigPCa [n (%)] 42 (100%)
Metastasis [n (%)] 28 (66.7%)